PUBLISHER: Grand View Research | PRODUCT CODE: 1941536
PUBLISHER: Grand View Research | PRODUCT CODE: 1941536
he global electrophysiology mapping and ablation devices market size was estimated at USD 30.89 billion in 2025 and is projected to reach USD 62.61 billion by 2033, growing at a CAGR of 8.2% from 2026 to 2033. Growing adoption of electrophysiology (EP) mapping and ablation devices for the diagnosis and treatment of complex arrhythmias, particularly atrial fibrillation, is a key driver of market growth.
Rising demand for advanced rhythm management tools in both hospital and ambulatory settings, coupled with the increasing burden of cardiac conditions among younger populations due to sedentary lifestyles, smoking, and alcohol use, is accelerating device utilization.According to a February 2024 article by Johnson & Johnson Services, Inc., over 37.5 million people globally are affected by atrial fibrillation. Roughly 1 in 4 adults over 40 is projected to develop the condition during their lifetime.
Global Electrophysiology Mapping And Ablation Devices Market Segmentation
This report forecasts revenue growth at global, regional & country levels and provides an analysis of the industry trends in each of the sub-segments from 2021 to 2033. for this study, Grand View Research has segmented the global electrophysiology mapping and ablation devices market report based on procedure type, product coverage, and region:
(*) The chapter will include the following:
(*) The chapter will include the following:
(*) For each country/region, the final report will provide: